Daniel Delorme

2.5k total citations
39 papers, 1.6k citations indexed

About

Daniel Delorme is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Daniel Delorme has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Organic Chemistry and 6 papers in Pharmacology. Recurrent topics in Daniel Delorme's work include Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (7 papers) and Fluorine in Organic Chemistry (4 papers). Daniel Delorme is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (7 papers) and Fluorine in Organic Chemistry (4 papers). Daniel Delorme collaborates with scholars based in Canada and Germany. Daniel Delorme's co-authors include Stephen Hanessian, Giliane Bouchain, Jeffrey M. Besterman, Zuomei Li, Y. LEBLANC, Serge Beaudoin, Marie-Claude Trachy-Bourget, Marielle Fournel, A. Robert MacLeod and Yvan Guindon and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Daniel Delorme

38 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Delorme Canada 23 852 812 238 138 102 39 1.6k
William V. Murray United States 27 894 1.0× 1.6k 1.9× 188 0.8× 164 1.2× 107 1.0× 100 2.3k
Atli Thorarensen United States 24 749 0.9× 1.2k 1.5× 156 0.7× 123 0.9× 105 1.0× 45 2.0k
John W. Ellingboe United States 25 893 1.0× 906 1.1× 122 0.5× 113 0.8× 56 0.5× 54 1.8k
Ji‐Wang Chern Taiwan 26 1.2k 1.4× 1.1k 1.3× 312 1.3× 157 1.1× 55 0.5× 116 2.2k
Michael J. Costanzo United States 25 637 0.7× 751 0.9× 88 0.4× 126 0.9× 72 0.7× 45 1.7k
Songnian Lin United States 23 840 1.0× 1.0k 1.3× 508 2.1× 175 1.3× 94 0.9× 45 1.9k
Gregory A. Reichard United States 19 542 0.6× 601 0.7× 298 1.3× 126 0.9× 121 1.2× 37 1.4k
Daniela Perrone Italy 27 957 1.1× 824 1.0× 156 0.7× 64 0.5× 70 0.7× 75 1.6k
Jefferson Tilley United States 20 683 0.8× 563 0.7× 160 0.7× 65 0.5× 39 0.4× 64 1.4k
Hitesh J. Sanganee United Kingdom 23 592 0.7× 741 0.9× 100 0.4× 70 0.5× 113 1.1× 37 1.3k

Countries citing papers authored by Daniel Delorme

Since Specialization
Citations

This map shows the geographic impact of Daniel Delorme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Delorme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Delorme more than expected).

Fields of papers citing papers by Daniel Delorme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Delorme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Delorme. The network helps show where Daniel Delorme may publish in the future.

Co-authorship network of co-authors of Daniel Delorme

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Delorme. A scholar is included among the top collaborators of Daniel Delorme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Delorme. Daniel Delorme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Paul A., Andrew M. Griffin, Lars Gawell, et al.. (2009). N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: The development of diaryl amino piperidines as potent δ opioid receptor agonists with in vivo anti-nociceptive activity in rodent models. Bioorganic & Medicinal Chemistry Letters. 19(21). 5994–5998. 12 indexed citations
2.
Llewellyn, David B., Naomy Bernstein, Stephen Claridge, et al.. (2009). SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes. Bioorganic & Medicinal Chemistry Letters. 19(10). 2747–2751. 35 indexed citations
3.
Llewellyn, David B., Stephen Claridge, Naomy Bernstein, et al.. (2009). Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(10). 2742–2746. 44 indexed citations
4.
Tanaka, Kelly S.E., Tom J. Houghton, Ting Kang, et al.. (2008). Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis. Bioorganic & Medicinal Chemistry. 16(20). 9217–9229. 36 indexed citations
5.
Fournel, Marielle, Claire Bonfils, Yu Hou, et al.. (2008). MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo. Molecular Cancer Therapeutics. 7(4). 759–768. 271 indexed citations
6.
Greenberg, Barry, Lara Fallon, Caroline Lagacé, et al.. (2007). P‐192: Tramiprosate decreases amyloid‐β induced ERK1/2 activity in primary rat neurons by a GABA‐independent pathway. Alzheimer s & Dementia. 3(3S_Part_2). 1 indexed citations
7.
Grimm, Erich L., Christine Brideau, Nathalie Chauret, et al.. (2006). Substituted coumarins as potent 5-lipoxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(9). 2528–2531. 44 indexed citations
8.
Ciblat, Stéphane, Adam Belley, Evelyne Dietrich, et al.. (2005). Novel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC. Bioorganic & Medicinal Chemistry Letters. 16(4). 891–896. 17 indexed citations
9.
Zhou, Nancy, Marielle Fournel, Daniel Delorme, et al.. (2004). 83 Antitumor activities of MGCD0103, a novel isotype-selective histone deacetylase inhibitor. European Journal of Cancer Supplements. 2(8). 28–28. 2 indexed citations
10.
Vaisburg, Arkadii, Naomy Bernstein, Sylvie Fréchette, et al.. (2003). (2-Amino-phenyl)-amides of ω-substituted alkanoic acids as new histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 283–287. 21 indexed citations
11.
Bouchain, Giliane & Daniel Delorme. (2003). Novel Hydroxamate and Anilide Derivatives as Potent Histone Deacetylase Inhibitors: Synthesis and Antiproliferative Evaluation. Current Medicinal Chemistry. 10(22). 2359–2372. 69 indexed citations
12.
Bouchain, Giliane, Silvana Leit, Sylvie Fréchette, et al.. (2003). Development of Potential Antitumor Agents. Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors. Journal of Medicinal Chemistry. 46(5). 820–830. 52 indexed citations
13.
Bouchain, Giliane, Sylvie Fréchette, Soon Hyung Woo, et al.. (2001). Design and synthesis of a novel class of histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(21). 2847–2850. 52 indexed citations
14.
Delorme, Daniel, Yves Ducharme, Christine Brideau, et al.. (1996). Dioxabicyclooctanyl Naphthalenenitriles as Nonredox 5-Lipoxygenase Inhibitors:  Structure−Activity Relationship Study Directed toward the Improvement of Metabolic Stability. Journal of Medicinal Chemistry. 39(20). 3951–3970. 51 indexed citations
15.
Guindon, Yvan, Christiane Yoakim, Vida Gorys, et al.. (1994). Stereoselective Hydrogen Transfer Reactions Involving Acyclic Radicals. Tandem Substituted Tetrahydrofuran Formation and Stereoselective Reduction: Synthesis of the C17-C22 Subunit of Ionomycin. The Journal of Organic Chemistry. 59(5). 1166–1178. 46 indexed citations
16.
Hutchinson, John H., Denis Riendeau, Christine Brideau, et al.. (1993). Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816. Journal of Medicinal Chemistry. 36(19). 2771–2787. 37 indexed citations
17.
Hanessian, Stephen, Youssef L. Bennani, & Daniel Delorme. (1990). The asymmetric synthesis of α-chloro α-alkyl and α-methyl α-alkyl phosphonic acids of high enantiomeric purity.. Tetrahedron Letters. 31(45). 6461–6464. 59 indexed citations
18.
Tagari, Philip, et al.. (1990). Comparison of urinary leukotriene E4 and 16-carboxytetranordihydro leukotriene E4 excretion in allergic asthmatics after inhaled antigen.. PubMed. 3(2). 75–80. 27 indexed citations
19.
Guindon, Yvan & Daniel Delorme. (1987). Total synthesis of leukotriene B4 analogues: 3-thia-LTB4 and 3-thia-20,20,20-trifluoro-LTB4. Canadian Journal of Chemistry. 65(6). 1438–1440. 3 indexed citations
20.
Hanessian, Stephen, et al.. (1984). Mild cleavage of methoxymethyl (MOM) ethers with trimethylsilyl bromide. Tetrahedron Letters. 25(24). 2515–2518. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026